Business · 18/01/2012Updated: 10/17/2026 · 1 min read

FDA Clears Darunavir Tablets for Approval

The FDA has determined that PREZISTA Tablets, 300mg, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of darunavir tablets, 300mg, through abbreviated new drug applications.